Pictet & Cie (Europe) Sa Exact Sciences Corp Transaction History

Pictet & Cie (Europe) Sa

$4.64 Billion
Q2 2025

A detailed history of Pictet & Cie (Europe) Sa transactions in Exact Sciences Corp stock. As of the latest transaction made, Pictet & Cie (Europe) Sa holds 163,204 shares of EXAS stock, worth $7.91 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

163,204

Previous 128,290 27.21%

Holding current value

$7.91 Million

Previous $5.55 Million 56.17%

% of portfolio

0.19%

Previous 0.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	BUY	$40.31 - $58.08 $1.41 Million - $2.03 Million	34,914 Added 27.21%	163,204 $8.67 Million
Q1 2025 Apr 17, 2025	SELL	$43.04 - $58.51 $31,591 - $42,946	-734 Reduced 0.57%	128,290 $5.55 Million
Q4 2024 Jan 30, 2025	BUY	$49.33 - $71.97 $76,313 - $111,337	1,547 Added 1.21%	129,024 $7.25 Million
Q3 2024 Oct 22, 2024	SELL	$42.43 - $70.83 $347,926 - $580,806	-8,200 Reduced 6.04%	127,477 $8.68 Million
Q2 2024 Jul 25, 2024	SELL	$41.33 - $74.26 $1.2 Million - $2.15 Million	-28,962 Reduced 17.59%	135,677 $5.73 Million
Q1 2024 May 07, 2024	BUY	$56.27 - $73.77 $1.76 Million - $2.31 Million	31,339 Added 23.51%	164,639 $11.4 Million
Q4 2023 Feb 09, 2024	BUY	$59.06 - $75.72 $789,573 - $1.01 Million	13,369 Added 11.15%	133,300 $9.86 Million
Q3 2023 Nov 02, 2023	BUY	$65.94 - $99.04 $448,457 - $673,571	6,801 Added 6.01%	119,931 $8.18 Million
Q2 2023 Aug 08, 2023	SELL	$62.68 - $95.05 $1.86 Million - $2.82 Million	-29,664 Reduced 20.77%	113,130 $10.6 Million
Q1 2023 May 01, 2023	SELL	$47.19 - $70.77 $27,087 - $40,621	-574 Reduced 0.4%	142,794 $9.68 Million
Q4 2022 Feb 08, 2023	BUY	$30.35 - $53.15 $201,979 - $353,713	6,655 Added 4.87%	143,368 $0
Q3 2022 Nov 10, 2022	SELL	$31.97 - $49.37 $14,098 - $21,772	-441 Reduced 0.32%	136,713 $4.44 Billion
Q2 2022 Aug 05, 2022	SELL	$35.61 - $76.23 $601,809 - $1.29 Million	-16,900 Reduced 10.97%	137,154 $5.4 Million
Q1 2022 May 04, 2022	BUY	$57.56 - $82.54 $101,823 - $146,013	1,769 Added 1.16%	154,054 $10.8 Million
Q4 2021 Feb 02, 2022	SELL	$72.5 - $100.68 $9.55 Million - $13.3 Million	-131,783 Reduced 46.39%	152,285 $11.9 Million
Q3 2021 Nov 10, 2021	BUY	$90.24 - $124.05 $814,055 - $1.12 Million	9,021 Added 3.28%	284,068 $27.1 Million
Q2 2021 Aug 11, 2021	BUY	$93.66 - $139.27 $17.1 Million - $25.4 Million	182,599 Added 197.52%	275,047 $34.2 Million
Q1 2021 May 10, 2021	BUY	$116.57 - $155.01 $4.28 Million - $5.7 Million	36,745 Added 65.97%	92,448 $12.2 Million
Q4 2020 Feb 11, 2021	SELL	$99.61 - $142.12 $653,541 - $932,449	-6,561 Reduced 10.54%	55,703 $7.38 Million
Q3 2020 Nov 10, 2020	SELL	$72.92 - $102.01 $7.51 Million - $10.5 Million	-102,955 Reduced 62.31%	62,264 $6.35 Million
Q2 2020 Aug 13, 2020	BUY	$55.75 - $92.75 $2.92 Million - $4.86 Million	52,397 Added 46.44%	165,219 $14.4 Million
Q1 2020 Apr 30, 2020	BUY	$37.9 - $104.44 $4.14 Million - $11.4 Million	109,312 Added 3114.3%	112,822 $6.54 Million
Q4 2019 Jan 31, 2020	BUY	$77.66 - $99.74 $272,586 - $350,087	3,510 New	3,510 $325,000

Others Institutions Holding EXAS

# of Institutions

644

Shares Held

157M

Call Options Held

1.83M

Put Options Held

1.56M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.58B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.

Account

Pictet & Cie (Europe) Sa Exact Sciences Corp Transaction History